Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-002553-80Phase 4Completed
Phase 4, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Karolinska University Hospital. Primary endpoint: Change in ADHD symptoms. Started May 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-002553-80.